D2-02: Excision repair cross complementing 6 (ERCC6) single nucleotide polymorphism (SNP) and outcome to gemcitabine(gem)/cisplatin(cis) or docetaxel(doc)/cis in stage IV non-small-cell lung cancer (NSCLC) patients (p)
2007
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI